In conclusion, our results suggested that GLP2 promotes the osteogenic differentiation from osteosarcoma cells and inhibits the growth of osteosarcoma, indicating that GLP2 therapy could be a valuable approach to promote bone regeneration and to inhibit osteosarcogenesis. This evidence concerns the gene GCG and osteosarcoma.